AzTrials
AzTrials

Heart Failure and Reduced Ejection FractionNCT07660237

Effects of a Transitional Care Program on Depression, Self-Efficacy, and Self-Care in Patients With Heart Failure

A study testing Structured Transitional Care Program in people with Heart Failure and Reduced Ejection Fraction and Transitional Care, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effects of a structured transitional care program on depression, self-efficacy, and self-care behaviors in patients with heart failure. Outcomes will be assessed before discharge and at 1 and 3 months after discharge. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Structured Transitional Care Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteTaiwan
Study dates
19 Jul 2023to 25 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with a diagnosis of heart failure confirmed by a specialist physician. Patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤40%.
  • Age ≥20 years. Clear consciousness and no cognitive impairment. Ability to communicate in Mandarin, Taiwanese, or Hakka. Ability to complete the questionnaire independently or with assistance from the researcher.

Who cannot join

  • Patients who are unable to be discharged during the current hospitalization. Severe consciousness impairment, cognitive impairment, or severe mental illness affecting study participation.
  • Patients who are illiterate or unable to express themselves verbally. Patients who are bedridden long-term or unable to perform self-care activities. Patients who refuse to participate in the study. Patients who are already enrolled in a case management program.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chang Gung Memorial Hospital

    Guishan, Taoyuan City, 33305

Other trials in Taiwan

About this study

Official title: Effects of a Transitional Care Program on Depression, Self-Efficacy, and Self-Care in Patients With Heart Failure: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of a structured transitional care program on depression, self-efficacy, and self-care behaviors in patients with heart failure. Outcomes will be assessed before discharge and at 1 and 3 months after discharge.

Read the detailed description

Heart failure is a chronic condition associated with frequent hospitalizations, poor self-care behaviors, psychological distress, and reduced quality of life. Patients with heart failure often experience depression and inadequate self-management after hospital discharge, which may negatively affect treatment adherence and clinical outcomes.

Transitional care programs have been developed to improve continuity of care and support patients during the transition from hospital to home. Structured transitional care interventions may enhance patients' self-efficacy and self-care abilities while reducing depressive symptoms.

This randomized controlled trial aims to evaluate the effects of a structured transitional care program on depression, self-efficacy, and self-care behaviors in patients with heart failure. Eligible participants will be randomly assigned to either the intervention group or the usual care group. The intervention group will receive a structured transitional care program in addition to usual care, whereas the control group will receive usual care only.

Outcomes including depression, self-efficacy, and self-care behaviors will be measured before discharge and at 1 and 3 months after discharge using validated assessment instruments.

Being tested
Structured Transitional Care Program, Usual Care
Keywords
Depression, Self-Efficacy, Self-Care
Medical subject headings
Heart Failure, Systolic, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured Transitional Care ProgramBehavioural

    A structured transitional care program including discharge education, telephone follow-up, and home care support for 3 months after discharge.

  • Usual CareOther

    Participants received standard discharge routine care provided by the hospital after discharge.

Study groups in NCT07660237
Study groupRoleWhat they receive
Transitional Care Program GroupExperimentalParticipants received a structured transitional care program including discharge education, telephone follow-up, and home care support for 3 months after discharge.
Receives: Behavioral: Structured Transitional Care Program
Usual Care GroupActive comparatorParticipants received routine discharge education and standard follow-up care provided by the hospital after dischar
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression Score Measured by the Patient Health Questionnaire-9 (PHQ-9)

    Depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9).

    Measured: Baseline (before discharge), 1 month after discharge, and 3 months after discharge.

  2. Change in Self-Efficacy Score Measured by the General Self-Efficacy Scale (GSES)

    Self-efficacy will be assessed using the General Self-Efficacy Scale (GSES).

    Measured: Baseline (before discharge), 1 month after discharge, and 3 months after discharge.

  3. Change in Self-Care Behavior Score Measured by the Self-Care of Heart Failure Index (SCHFI)

    Self-care behaviors will be assessed using the Self-Care of Heart Failure Index (SCHFI).

    Measured: Baseline (before discharge), 1 month after discharge, and 3 months after discharge.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2026
  2. Study start19 Jul 2023
  3. Primary completion18 Jan 2024
  4. Study completion25 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to either the structured transitional care program group or the usual care group in a parallel design.
Masking
None (open label)
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07660237
Sponsor's protocol ID
202300968B0
Status last verified
May 2026
First submitted
12 Jun 2026
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Structured Transitional Care Program in people with Heart Failure and Reduced Ejection Fraction and Transitional Care, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression Score Measured by the Patient Health Questionnaire-9 (PHQ-9) (time frame: Baseline (before discharge), 1 month after discharge, and 3 months after discharge.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in